Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice

被引:61
|
作者
Qin, Wei [1 ]
Du, Ning [1 ]
Zhang, Longyin [1 ]
Wu, Xianxian [1 ]
Hu, Yingying [1 ]
Li, Xiaoguang [1 ]
Shen, Nannan [1 ]
Li, Yang [1 ]
Yang, Baofeng [1 ,2 ]
Xu, Chaoqian [1 ]
Fang, Zhiwei [1 ]
Lu, Yanjie [1 ,2 ]
Zhang, Yong [1 ,2 ]
Du, Zhimin [3 ]
机构
[1] Harbin Med Univ, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Key Lab Cardiovasc Res,Minist Educ, Harbin 150081, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Inst Cardiovasc Res, Harbin 150081, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharm, Harbin 150081, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
GROWTH-FACTOR; MYOCARDIAL-INFARCTION; SYSTOLIC DYSFUNCTION; EXTRACELLULAR-MATRIX; DOWN-REGULATION; HEART-FAILURE; CONCISE GUIDE; EXPRESSION; PATHWAY; PROLIFERATION;
D O I
10.1111/bph.13002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and PurposePressure overload-induced cardiac interstitial fibrosis is viewed as a major cause of heart failure in patients with hypertension or aorta atherosclerosis. The purpose of this study was to investigate the effects and the underlying mechanisms of genistein, a natural phytoestrogen found in soy bean extract, on pressure overload-induced cardiac fibrosis. Experimental ApproachGenisten was administered to mice with pressure overload induced by transverse aortic constriction. Eight weeks later, its effects on cardiac dysfunction, hypertrophy and fibrosis were determined. Its effects on proliferation, collagen production and myofibroblast transformation of cardiac fibroblasts (CFs) and the signalling pathways were also assessed in vitro. Key ResultsPressure overload-induced cardiac dysfunction, hypertrophy and fibrosis were markedly attenuated by genistein. In cultured CFs, genistein inhibited TGF1-induced proliferation, collagen production and myofibroblast transformation. Genistein suppressed TGF-activated kinase 1 (TAK1) expression and produced anti-fibrotic effects by blocking the TAK1/MKK4/JNK pathway. Further analysis indicated that it up-regulated oestrogen-dependent expression of metastasis-associated gene 3 (MTA3), which was found to be a negative regulator of TAK1. Silencing MTA3 by siRNA, or inhibiting the activity of the MTA3-NuRD complex with trichostatin A, abolished genistein's anti-fibrotic effects. Conclusions and ImplicationsGenistein improved cardiac function and inhibited cardiac fibrosis in response to pressure overload. The underlying mechanism may involve regulation of the MTA3/TAK1/MKK4/JNK signalling pathway. Genistein may have potential as a novel agent for prevention and therapy of cardiac disorders associated with fibrosis. Linked ArticlesThis article is part of a themed section on Chinese Innovation in Cardiovascular Drug Discovery. To view the other articles in this section visit http://dx. doi. org/10.1111/bph. 2015.172. issue-23
引用
收藏
页码:5559 / 5572
页数:14
相关论文
共 50 条
  • [1] Hydrogen-containing saline alleviates pressure overload-induced interstitial fibrosis and cardiac dysfunction in rats
    Yang, Jing
    Wu, Shujing
    Zhu, Liqun
    Cai, Jingjing
    Fu, Lu
    MOLECULAR MEDICINE REPORTS, 2017, 16 (02) : 1771 - 1778
  • [2] Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice
    Goh, Kah Yong
    He, Li
    Song, Jiajia
    Jinno, Miki
    Rogers, Aaron J.
    Sethu, Palaniappan
    Halade, Ganesh, V
    Rajasekaran, Namakkal Soorappan
    Liu, Xiaoguang
    Prabhu, Sumanth D.
    Darley-Usmar, Victor
    Wende, Adam R.
    Zhou, Lufang
    REDOX BIOLOGY, 2019, 21
  • [3] Direct thrombin inhibition with dabigatran attenuates pressure overload-induced cardiac fibrosis and dysfunction in mice
    Dong, Anping
    Mueller, Paul
    Yang, Fanmuyi
    Yang, Liping
    Morris, Andrew
    Smyth, Susan S.
    THROMBOSIS RESEARCH, 2017, 159 : 58 - 64
  • [4] Direct Thrombin Inhibition with Dabigatran Attenuates Pressure Overload-Induced Cardiac Fibrosis and Diastolic Dysfunction in Mice
    Dong, Anping
    Yang, Liping
    Adrienne Nguyen
    Mueller, Paul
    Morris, Andrew
    Smyth, Susan
    CIRCULATION, 2012, 126 (21)
  • [5] Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction
    Zhang, Yan
    Zhang, Xiao-Fei
    Gao, Lu
    Liu, Yu
    Jiang, Ding-Sheng
    Chen, Ke
    Yang, Qinglin
    Fan, Guo-Chang
    Zhang, Xiao-Dong
    Huang, Congxin
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (02): : 232 - 244
  • [6] Roles of prostanoids in pressure overload-induced cardiomyocyte hypertrophy and cardiac fibrosis in mice
    Hara, A
    Yuhki, K
    Narumiya, S
    Ushikubi, F
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 193P - 193P
  • [7] Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice
    Lai, N. Chin
    Gao, Mei Hua
    Tang, Eric
    Tang, Ruoying
    Guo, Tracy
    Dalton, Nancy D.
    Deng, Aihua
    Tang, Tong
    LABORATORY INVESTIGATION, 2012, 92 (11) : 1518 - 1526
  • [8] Vitamin D attenuates pressure overload-induced cardiac remodeling and dysfunction in mice
    Zhang, Liang
    Yan, Xiao
    Zhang, Yun-Long
    Bai, Jie
    Hidru, Tesfaldet Habtemariam
    Wang, Qing-Shan
    Li, Hui-Hua
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 178 : 293 - 302
  • [9] Scleraxis Regulates Pressure Overload-Induced Cardiac Fibrosis
    Nagalingam, Raghu S.
    Cheung, David Y.
    Aroutiounova, Nina
    Jassal, Davinder S.
    Czubryt, Michael P.
    CIRCULATION, 2017, 136
  • [10] Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure
    Jin, Li
    Sun, Simei
    Ryu, Yuhee
    Piao, Zhe Hao
    Liu, Bin
    Choi, Sin Young
    Kim, Gwi Ran
    Kim, Hyung-Seok
    Kee, Hae Jin
    Jeong, Myung Ho
    SCIENTIFIC REPORTS, 2018, 8